SCHEMBL299356

SCHEMBL299356

CC1CCC(C(C)C)C(C(=O)Nc2cccc(C(N)=O)c2)C1

nearest known ligand 0.58

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 4/20 0.58
PARP1 P09874 9/20 0.58
PARP10 Q53GL7 8/20 0.58
PARP15 Q460N3 4/20 0.49
EPHX1 P07099 1/20 0.49
TRPV1 Q8NER1 1/20 0.46
APEX1 P27695 1/20 0.44
ALOX5AP P20292 1/20 0.43
PARP14 Q460N5 2/20 0.43
ALDH1A1 P00352 1/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2628779 1.00 TRPM8 (0.58) TRPM8PARP1PARP10PARP15EPHX1
SCHEMBL2628752 0.91 TRPM8 (0.61) TRPM8PARP1PARP10EPHX1TRPV1
SCHEMBL2628645 0.86 TRPM8 (0.70) TRPM8EPHX1TRPV1ALDH1A1MEN1
SCHEMBL291318 0.86 TRPM8 (0.70) TRPM8EPHX1TRPV1ALDH1A1MEN1
SCHEMBL15133466 0.85 TRPM8 (0.62) TRPM8EPHX1TRPV1ALDH1A1
SCHEMBL2628762 0.85 TRPM8 (0.62) TRPM8EPHX1TRPV1ALDH1A1
SCHEMBL10072944 0.84 TRPM8 (0.61) TRPM8EPHX1TRPV1ALDH1A1MEN1
SCHEMBL10073491 0.83 TRPM8 (0.73) TRPM8EPHX1MEN1KMT2A
SCHEMBL4817890 0.83 TRPM8 (0.73) TRPM8EPHX1MEN1KMT2A
SCHEMBL4143429 0.83 TRPM8 (0.60) TRPM8EPHX1TRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8664261-B2 Organic compounds having cooling properties GIVAUDAN S.A. (CH) 2014-03-04 US claimed
US-8377422-B2 Carboxamide derivatives having cooling properties GIVAUDAN S.A. (CH) 2013-02-19 US claimed
US-20120095042-A1 Organic Compounds Having Cooling Properties GIVAUDAN SA (CH) 2012-04-19 US claimed
US-20110182833-A1 Carboxamide Derivatives Having Cooling Properties GIVAUDAN SA (CH) 2011-07-28 US claimed
US-20100297038-A1 Benzimidazole Derivatives And Their Use As Cooling Agents GIVAUDAN S.A. (CH) 2010-11-25 US claimed
EP-2250154-A1 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS COOLING AGENTS Givaudan SA (CH) 2010-11-17 EP claimed
EP-2229352-A2 CARBOXAMIDE DERIVATIVES HAVING COOLING PROPERTIES Givaudan SA (CH) 2010-09-22 EP claimed
WO-2009089641-A1 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS COOLING AGENTS GIVAUDAN SA (CH) 2009-07-23 WO claimed
WO-2009070910-A2 CARBOXAMIDE DERIVATIEVES HAVING COOLING PROPERTIES GIVAUDAN SA (CH) 2009-06-11 WO claimed
EP-2296759-B1 COOLING COMPOSITION GIVAUDAN SA (CH) 2019-10-02 EP disclosed
CN-102036716-B Cooling composition GIVAUDAN S.A. (CH) 2016-02-10 CN disclosed
US-8664261-B2 Organic compounds having cooling properties GIVAUDAN S.A. (CH) 2014-03-04 US disclosed
US-8377422-B2 Carboxamide derivatives having cooling properties GIVAUDAN S.A. (CH) 2013-02-19 US disclosed
US-8288441-B2 Compositions comprising a physiological coolant GIVAUDAN NEDERLAND SERVICES B.V. (NL) 2012-10-16 US disclosed
EP-2229352-A2 CARBOXAMIDE DERIVATIVES HAVING COOLING PROPERTIES Givaudan SA (CH) 2010-09-22 EP disclosed
EP-2134319-A2 COMPOSITIONS COMPRISING A PHYSIOLOGICAL COOLANT Givaudan Nederland Services B.V. (NL) 2009-12-23 EP disclosed
WO-2009140783-A1 COOLING COMPOSITION GIVAUDAN SA (CH) 2009-11-26 WO disclosed
WO-2009089641-A1 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS COOLING AGENTS GIVAUDAN SA (CH) 2009-07-23 WO disclosed
WO-2009070910-A2 CARBOXAMIDE DERIVATIEVES HAVING COOLING PROPERTIES GIVAUDAN SA (CH) 2009-06-11 WO disclosed
WO-2008107137-A2 COMPOSITIONS COMPRISING A PHYSIOLOGICAL COOLANT GIVAUDAN NEDERLAND SERVICES B.V. (NL) 2008-09-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100297038-A1 Benzimidazole Derivatives And Their Use As Cooling Agents OR10J3, H1-3, ORC3 TRPM8 2049/4885PARP1 1925/4885PARP10 1618/4885
US-20110182833-A1 Carboxamide Derivatives Having Cooling Properties CPS1, NQO2, NDUFA2 TRPM8 376/4885PARP1 432/4885PARP10 448/4885
US-20120095042-A1 Organic Compounds Having Cooling Properties ME3, ME2, MSMO1 TRPM8 361/4885PARP1 1109/4885PARP10 1050/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.